Inactivity of delta9-tetrahydrocannabinol in antidepressant screening tests.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001285:Atropine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D002188:Cannabis / Q000494:pharmacology*; D013759:Dronabinol / Q000494:pharmacology; D004357:Drug Synergism; D007036:Hypothermia, Induced; D007099:Imipramine / Q000494:pharmacology; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D012472:Salivation / Q000187:drug effects; D013747:Tetrabenazine / Q000037:antagonists & inhibitors; D014202:Tremor / Q000139:chemically induced; D014203:Tremorine / Q000037:antagonists & inhibitors; D015016:Yohimbine / Q000633:toxicity
D000928:Antidepressive Agents; D015016:Yohimbine; D001285:Atropine; D013759:Dronabinol; D012110:Reserpine; D007099:Imipramine; D014203:Tremorine; D013747:Tetrabenazine